Capital.com
26.1.2024 13:03:55 CET | ACCESS Newswire | Press release
UK retail investors are bullish on equities but worry about the cost-of-living crisis, falling stock prices and geopolitical risks in the year ahead.
LONDON, UK / ACCESSWIRE / January 26, 2024 / Seven in 10 retail (77%) traders and investors in the UK are taking a neutral-to-optimistic view on financial markets in 2024, according to a new nationally representative survey commissioned by online retail trading platform, Capital.com- with 35% of respondents expecting stocks to be the best performing asset class over the next six to 12 months. These findings affirm that market confidence among UK investors remains high, despite wider macro risks.
The findings are based on a nationally representative survey of 19,451 UK adults, of which 2,036 are traders or investors. In this survey, investors and traders are defined as adults who had invested or traded in mutual funds, bonds, forex, commodities, options, CFDs or spread bets in the past 12 months. The survey, commissioned by Capital.com and polled by Find Out Now, was carried out between 21 Nov to 4 Dec 2023.
Commenting on the upbeat investor sentiment revealed by the findings of the survey, Daniela Hathorn, Senior Market Analyst, Capital.com, said:
"Supported by positive economic data at the tail end of 2023, investors are perhaps approaching 2024 with an air of optimism. Yes, there are pockets of weakness in the economy, especially in the UK and the euro area, but global economic growth in 2023 has fared much better than expected. Of course that doesn't mean the same will happen in 2024, but with investors widely expecting interest rates to fall this year, many expect the recent resilience to be carried through as looser financing conditions make up for some of the loss in productivity and growth."
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.The survey further revealed a healthy interest in equity markets, with 35% of respondents expecting stocks to do well in 2024 followed by gold (32%) and oil & gas (31%). Positive market sentiment was further reflected in investors' capital allocation decisions with 30% of respondents saying they would buy or trade stocks in the next six to 12 months -with the majority focusing on growth and tech stocks (52%). Just 9% said they would move their capital into cash over the same period.
According to Daniela, investors' preference for stocks over other asset classes in 2024 is likely the result of improving market conditions.
"Stocks are typically favoured by investors because they are considered the ‘most tangible' of all non-physical investments, which simply means they are easier to measure and understand than other asset classes. Add to that expectations for rate cuts in 2024 and you have the ideal impetus for equity market enthusiasts. With the potential for lower interest rates in 2024, investors are perhaps expecting company valuations to improve making them attractive investments. Tech stocks are renowned for being the market sweethearts as they tend to hold their value even in difficult times, while offering investors greater returns. Similarly, growth stocks can benefit from improved market sentiment and higher valuations."
Cost-of-living crisis results in greater awareness of saving & investing activities
Despite the market optimism, respondents cited the ongoing cost-of-living crisis as the biggest risk to their investment and trading returns with 22% of those surveyed saying they would need to free up investment capital to cover higher expenses.
Consumers have less money to play with, putting pressure on many to amend their trading, savings and investment habits. When asked what they would do with an extra £10,000, the majority of respondents (57%) said they would either put it into a savings account or trade or invest it. Just 10% said they would spend it while 14% said they would overpay their mortgage or put it into a pension plan (6%).
To view this piece of content from www.accesswire.com, please give your consent at the top of this page."The recent period of high inflation has led to a general devaluation of capital unless it was invested in an asset that provided higher returns. It is not surprising that people are more conscious about how they manage their money now that they have seen the cost of living increase exponentially -it is no longer enough to simply save, consumers want to make up for the loss in their purchasing power. This has led to more awareness about investing, leading many to increase their capital allocations to return-generating activities rather than spending," said Daniela.
Other concerns for UK traders and investors in 2024 include falling stock prices (20%) , geopolitical risk (18%) and recession (16%). Tellingly, only 9% said that higher interest rates were of concern to them, suggesting investors expect the UK economy to improve in the year ahead.
"Markets are currently pricing in between five to six 25 bps rate cuts in 2024 from the BoE. Meanwhile, the central bank itself is expecting to make around three rate cuts this year. These misaligned expectations could drive momentum in UK assets over the coming months, especially as upcoming economic data reveals which set of expectations appear to be correct. Nonetheless, rate cuts are expected so investors may be looking to get higher yields on bonds while they can," she added.
END
Notes to Editors
About Capital.com
Capital.com is a high-growth fintech company empowering people to participate in financial markets through simple and innovative online trading platforms. Its intuitive award-winning platform, available on web and app, enables investors to trade thousands of world-renowned markets. To help investors trade with confidence, the platform is fitted with robust risk management controls and transparent pricing while its all-in-one ‘Investmate' app delivers financial lessons and educational content to support clients in their investment journey. Capital.com has a global network with offices located in Cyprus, UK and Australia.
Capital Com (UK) Limited is authorised and regulated by the Financial Conduct Authority (FCA) under registration number 793714. Capital Com SV Investments Limited is Authorised and regulated by the Cyprus Securities and Exchange Commission (CySEC), under licence number 319/17. Capital Com Australia Pty Ltd is authorised and regulated by the Australian Securities and Investments Commission (ASIC) under AFSL Number 513393.
To find out more, please visit: www.capital.com
Disclosures
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money. Professional clients can lose more than they deposit. All trading involves risk. Please refer to our Risk Disclosure Statement.
Crypto Derivatives are not available to Retail clients registered with Capital Com (UK) Ltd.
The value of shares and ETFs bought through a share dealing account can fall as well as rise, which could mean getting back less than you originally put in. Past performance is no guarantee of future results.
Capital Com (UK) Limited ("CCUK") is registered in England and Wales with company registration number 10506220. CCUK is authorised and regulated by the Financial Conduct Authority ("FCA"), under registration number 793714."
Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.
Any information which could be construed as "investment research" has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.
Shamillia Sivathambu
+44 79000 16469
shamillia.sivathambu@capital.com
SOURCE: Capital.com
View the original press release on accesswire.com
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
LiberNovo 2026 Triple Launch: SE, Pro, and Maxis Introduce Dynamic Ergonomics for Every Body Type Across Europe18.5.2026 19:00:00 CEST | Press release
LONDON, GB / ACCESS Newswire / May 18, 2026 / LiberNovo, the premium ergonomic chair brand pioneering movement-based seating, today confirmed the full details of its 2026 product expansion for the European market. Three new lines-the Omni SE, Omni Pro, and the all-new Maxis series-will be available to customers across the UK and EU starting June 16, with pre-orders now open. Across Europe, the shift toward hybrid and remote work has turned the home office into a permanent fixture. Yet the chair at the centre of that setup is often the last thing to be upgraded. Most ergonomic seating still operates on a decades-old premise: find the correct posture, lock it in, stay put. LiberNovo rejects that model entirely. Its Dynamic Ergonomics platform is built around continuous adaptation-chairs that respond to how users actually move through their day, rather than forcing them into a fixed position. With three distinct product lines, that approach now reaches users of every build and budget. Omn
Europe's Healthcare IT Market Enters the 2027 Readiness Cycle as Black Book Names 26 Top Client-Rated Vendors During HIMSS26 Week in Copenhagen18.5.2026 18:00:00 CEST | Press release
Category-specific honors identify client-rated leaders in data-ready EHRs, interoperability, enterprise imaging, cloud, cybersecurity, AI, advisory, analytics, clinical decision support and digital health infrastructure COPENHAGEN, DK / ACCESS Newswire / May 18, 2026 / Black Book Research today announced its 2026 European Healthcare IT Client Satisfaction Honors, recognizing 26 healthcare technology vendors and platforms whose strongest client-facing performance aligns with the next phase of European digital health: trusted data, cross-border interoperability, AI accountability, cybersecurity resilience, cloud modernization, enterprise imaging liquidity, analytics readiness and clinical workflow transformation. The announcement is timed to HIMSS26 Europe, taking place 19-21 May 2026 at the Bella Center in Copenhagen, Denmark, where healthcare leaders, innovators and policymakers are convening around digital maturity, AI, interoperability, cybersecurity and health system transformation.
Tyson Fury, The Gypsy King, Joins Datavault AI as International Spokesperson to Champion Athlete Data Monetization18.5.2026 14:37:00 CEST | Press release
Forbes' Third Highest-Paid Athlete in the World Brings Global Platform to Datavault AI's Sports Illustrated Exchange and NIL Monetization Initiative PHILADELPHIA, PA / ACCESS Newswire / May 18, 2026 / Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a provider of data monetization, credentialing, digital engagement, and real-world asset (‘RWA') tokenization technologies, today announced that two-time world heavyweight champion Tyson Fury has signed on as International Spokesperson for Datavault AI a deal brokered by Nick Hunter of P11. Ranked No. 3 on Forbes' 2025 list of the world's highest-paid athletes with $146 million in estimated earnings (Forbes 2025), Fury brings global star power, and a uniquely personal understanding of what it means to own, protect, and capitalize on a name, to Datavault AI's mission of empowering individuals and organizations to monetize their data and digital assets. Known worldwide as "The Gypsy King," his appointment immediately precede
Tabor Redefines Anti-Drone Testing with Software-Defined SDR Platform15.5.2026 22:55:00 CEST | Press release
NESHER, ISRAEL / ACCESS Newswire / May 15, 2026 / Tabor Electronics today announced the commercial release of its Anti-Drone Test and Evaluation (T&E) solution, introducing a software-defined approach to validating counter-unmanned aircraft systems (C-UAS). Built on the company's Proteus™ Software Defined Radio (SDR) platform, the solution enables defense and security organizations to test and deploy counter-drone technologies in rapidly changing threat environments. As low-cost drones proliferate and communication protocols evolve, traditional hardware-bound test environments are struggling to keep pace. Tabor's platform replaces these constraints with a programmable framework that allows engineering teams to emulate and validate real-world RF scenarios in controlled lab environments-reducing reliance on extended field testing while accelerating development timelines. Originally developed in collaboration with leading anti-drone technology companies, the solution has already been prov
Wellgistics Health Accelerates Digital Health Expansion of its Newly Announced RPM, RTM and CCM Pilot with Planned Acquisition of WellCare Today and its Proprietary Samsung Galaxy Watch Care Monitoring Program14.5.2026 21:05:00 CEST | Press release
Highlights: WellCare Today brings established RPM, RTM and CCM infrastructure with wearable technology integrations and connected monitoring solutions Combination expected to integrate Wellgistics Health recently announced MSO initiative with Kare Clinicals and its network of 6,500+ independent pharmacies Proposed platform designed to enhance patient engagement, medication adherence, remote monitoring and longitudinal care coordination Proposed transaction valued at approximately $15 million Strategic initiative intended to create additional clinical revenue opportunities for participating pharmacies and providers TAMPA, FL / ACCESS Newswire / May 14, 2026 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics" or the "Company"), a leading healthcare technology and pharmaceutical distribution company, today announced that it has executed a non-binding letter of intent ("LOI") to acquire WellCare Today. The proposed transaction structure includes a structured cash payment of $3 million,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
